Skip to content

Clinical trials

Completed COVID-19 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Status: Completed Country / region: Taiwan Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202011
202110
202211
20236
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital9
Gilead Sciences2
Pfizer2
St. Martin De Porress Hospital2
Tri-Service General Hospital (TSGH)2
United Biomedical Inc., Asia2
Adimmune Corporation1
Advagene Biopharma Co. Ltd.1
AstraZeneca1
Chang Gung Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1941
Influenza, Human3
Anxiety Disorders2
Coronavirus Infections2
Critical Illness2
Post-Acute COVID-19 Syndrome2
Acne Vulgaris1
Dyspnea1
Emergencies1
Heart Defects, Congenital1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.